BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23271457)

  • 1. The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.
    Jacobsen C; Zemann W; Obwegeser JA; Grätz KW; Metzler P
    Oral Maxillofac Surg; 2014 Mar; 18(1):31-7. PubMed ID: 23271457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the cause of "phossy jaw" Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed.
    Marx RE
    J Oral Maxillofac Surg; 2008 Nov; 66(11):2356-63. PubMed ID: 18940506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development.
    Ruggiero SL
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):13-8. PubMed ID: 19371810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report].
    Selvi Sabater P; Rizo Cerdá AM; Titos Arcos JC; Espuny Miró A
    Farm Hosp; 2014 May; 38(3):248-9. PubMed ID: 24951910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
    Aoki K; Matsunaga S; Ito S; Shibahara T; Nomura T; Matsuzaki H; Abe S; Yamaguchi A
    J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab and osteonecrosis of the jaws - the pharmacology, pathogenesis and a report of two cases.
    O'Halloran M; Boyd NM; Smith A
    Aust Dent J; 2014 Dec; 59(4):516-9. PubMed ID: 25131835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of current literature and implications of RANKL inhibitors for oral health care providers.
    Epstein MS; Ephros HD; Epstein JB
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Dec; 116(6):e437-42. PubMed ID: 22901640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?
    Hellstein JW; Marek CL
    J Oral Maxillofac Surg; 2005 May; 63(5):682-9. PubMed ID: 15883944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
    Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
    J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab.
    Neuprez A; Coste S; Rompen E; Crielaard JM; Reginster JY
    Osteoporos Int; 2014 Jan; 25(1):393-5. PubMed ID: 23835864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaws.
    Toole J
    Rheumatology (Oxford); 2015 Oct; 54(10):1755-6. PubMed ID: 25877909
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
    Yoneda T
    Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteochemonecrosis: an overview.
    Hellstein J
    Head Neck Pathol; 2014 Dec; 8(4):482-90. PubMed ID: 25409847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonate-associated osteonecrosis of the jaw].
    Abu-Id MH; Açil Y; Gottschalk J; Kreusch T
    Mund Kiefer Gesichtschir; 2006 Mar; 10(2):73-81. PubMed ID: 16456688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.